18 Jun 2012 07:00

Port Erin Biopharma Investments Limited
Â
 ("Port Erin" or the "Company")
Â
Director's Dealing
Â
Â
Port Erin, the AIM listed company focused on investing in the biotechnology and biopharmaceutical sectors, was informed that Galloway Limited purchased 500,000 Ordinary Shares at a price of 7 pence per share on 15 June 2012.
Â
Galloway Limited is wholly owned by a trust in which Jim Mellon, Chairman of the Company, has a life tenancy. Denham Eke, a Director of the Company, is a director of Galloway Limited.
Â
Following this transaction, the total Ordinary Shares in which Jim Mellon has a beneficial interest is 3,941,000, representing 11.8% of the issued ordinary share capital of the Company.
Â
Â
Enquiries:
Â
 | |||
Port Erin Biopharma Investments Limited | Â | ||
Denham Eke | (+44) 1624 639396 | ||
 |  | ||
Libertas Capital Corporate Finance Limited | Â | ||
Sandy Jamieson | (+44) 20 7569 9650 | ||
 |  | ||
Rivington Street Corporate Finance Limited | Â | ||
John Levinson | (+44) 20 7562 3350 | ||
Â